ha 1004 has been researched along with Leukemia, Myeloid in 2 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matikainen, S | 1 |
| Serkkola, E | 1 |
| Hurme, M | 1 |
| Bernstein, SH | 1 |
| Kharbanda, SM | 1 |
| Sherman, ML | 1 |
| Stone, RM | 1 |
| Kufe, DW | 1 |
2 other studies available for ha 1004 and Leukemia, Myeloid
| Article | Year |
|---|---|
Retinoic acid enhances IL-1 beta expression in myeloid leukemia cells and in human monocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Blotting, Northern; Bucladesine; Gene Expression; Hum | 1991 |
Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Blotting, Northern; Cell Line; Enzyme Acti | 1991 |